157 related articles for article (PubMed ID: 11409869)
21. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
22. Hirschsprung associated GDNF mutations do not prevent RET activation.
Borghini S; Bocciardi R; Bonardi G; Matera I; Santamaria G; Ravazzolo R; Ceccherini I
Eur J Hum Genet; 2002 Mar; 10(3):183-7. PubMed ID: 11973622
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B).
Svensson PJ; Anvret M; Molander ML; Nordenskjöld A
Hum Genet; 1998 Aug; 103(2):145-8. PubMed ID: 9760196
[TBL] [Abstract][Full Text] [Related]
24. Glial cell line-derived neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a subpopulation of patients with Hirschsprung's disease.
Lui VC; Samy ET; Sham MH; Mulligan LM; Tam PK
Lab Invest; 2002 Jun; 82(6):703-12. PubMed ID: 12065680
[TBL] [Abstract][Full Text] [Related]
25. Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours.
Gimm O; Gössling A; Marsh DJ; Dahia PL; Mulligan LM; von Deimling A; Eng C
Br J Cancer; 1999 May; 80(3-4):383-6. PubMed ID: 10408842
[TBL] [Abstract][Full Text] [Related]
26. Functional characterization of mutations in the GDNF gene of patients with Hirschsprung disease.
Eketjäll S; Ibáñez CF
Hum Mol Genet; 2002 Feb; 11(3):325-9. PubMed ID: 11823451
[TBL] [Abstract][Full Text] [Related]
27. Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families.
Fitze G; Cramer J; Serra A; Schreiber M; Roesner D; Schackert HK
Eur J Pediatr Surg; 2003 Jun; 13(3):152-7. PubMed ID: 12939698
[TBL] [Abstract][Full Text] [Related]
28. [From monogenic to polygenic: model of Hirschsprung disease].
Salomon R; Amiel J; Attié T; Pelet A; Munnich A; Lyonnet S
Pathol Biol (Paris); 1998 Nov; 46(9):705-7. PubMed ID: 9885824
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
[TBL] [Abstract][Full Text] [Related]
30. [Molecular basis of Hirschsprung disease].
Inoue M; Okada A
Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
[TBL] [Abstract][Full Text] [Related]
31. Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.
Kanai M; Numakura C; Sasaki A; Shirahata E; Akaba K; Hashimoto M; Hasegawa H; Shirasawa S; Hayasaka K
Tohoku J Exp Med; 2002 Apr; 196(4):241-6. PubMed ID: 12086152
[TBL] [Abstract][Full Text] [Related]
32. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.
Borrego S; Sáez ME; Ruiz A; Gimm O; López-Alonso M; Antiñolo G; Eng C
J Med Genet; 1999 Oct; 36(10):771-4. PubMed ID: 10528857
[TBL] [Abstract][Full Text] [Related]
33. Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.
Edery P; Pelet A; Mulligan LM; Abel L; Attié T; Dow E; Bonneau D; David A; Flintoff W; Jan D
J Med Genet; 1994 Aug; 31(8):602-6. PubMed ID: 7815416
[TBL] [Abstract][Full Text] [Related]
34. Assignment of mouse Gfra1, the homologue of a new human HSCR candidate gene, to the telomeric region of mouse chromosome 19.
Puliti A; Cinti R; Seri M; Ceccherini I; Romeo G
Cytogenet Cell Genet; 1997; 78(3-4):291-4. PubMed ID: 9465906
[TBL] [Abstract][Full Text] [Related]
35. GDNF family receptors in the embryonic and postnatal rat heart and reduced cholinergic innervation in mice hearts lacking ret or GFRalpha2.
Hiltunen JO; Laurikainen A; Airaksinen MS; Saarma M
Dev Dyn; 2000 Sep; 219(1):28-39. PubMed ID: 10974669
[TBL] [Abstract][Full Text] [Related]
36. Segregation at three loci explains familial and population risk in Hirschsprung disease.
Gabriel SB; Salomon R; Pelet A; Angrist M; Amiel J; Fornage M; Attié-Bitach T; Olson JM; Hofstra R; Buys C; Steffann J; Munnich A; Lyonnet S; Chakravarti A
Nat Genet; 2002 May; 31(1):89-93. PubMed ID: 11953745
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the RET proto-oncogene in Hirschsprung's disease.
Edery P; Lyonnet S; Mulligan LM; Pelet A; Dow E; Abel L; Holder S; Nihoul-Fékété C; Ponder BA; Munnich A
Nature; 1994 Jan; 367(6461):378-80. PubMed ID: 8114939
[TBL] [Abstract][Full Text] [Related]
38. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.
Gimm O; Dziema H; Brown J; Hoang-Vu C; Hinze R; Dralle H; Mulligan LM; Eng C
Oncogene; 2001 Apr; 20(17):2161-70. PubMed ID: 11360200
[TBL] [Abstract][Full Text] [Related]
39. Expression pattern of GDNF, c-ret, and GFRalphas suggests novel roles for GDNF ligands during early organogenesis in the chick embryo.
Homma S; Oppenheim RW; Yaginuma H; Kimura S
Dev Biol; 2000 Jan; 217(1):121-37. PubMed ID: 10625540
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain.
Iwashita T; Murakami H; Asai N; Takahashi M
Hum Mol Genet; 1996 Oct; 5(10):1577-80. PubMed ID: 8894691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
